Raymond James Financial Services Advisors’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$709K Buy
100,073
+35,808
+56% +$254K ﹤0.01% 2388
2024
Q2
$419K Buy
64,265
+9,377
+17% +$61.1K ﹤0.01% 2658
2024
Q1
$456K Sell
54,888
-3,465
-6% -$28.8K ﹤0.01% 2585
2023
Q4
$642K Sell
58,353
-1,681
-3% -$18.5K ﹤0.01% 2246
2023
Q3
$505K Buy
60,034
+1,300
+2% +$10.9K ﹤0.01% 2322
2023
Q2
$738K Buy
+58,734
New +$738K ﹤0.01% 2100